News & Updates

Show Multimedia Only

ICI efficacy in lung cancer not dictated by time of treatment

27 Apr 2026 by

In lung cancer patients receiving immune checkpoint inhibitors (ICIs), survival is not necessarily better when treatment is administered in the morning vs in the afternoon, according to the i-TIMES study.

ICI efficacy in lung cancer not dictated by time of treatment

27 Apr 2026

Sleep apnoea common among long COVID patients, signalled by insomnia

25 Apr 2026 by

More than 80 percent of patients with long COVID have obstructive sleep apnoea (OSA), and these patients present with insomnia rather than the classic excessive daytime sleepiness, according to new research.

Sleep apnoea common among long COVID patients, signalled by insomnia

25 Apr 2026

16-year HK study: Borderline personality disorder ups risks of physical diseases and mortality

24 Apr 2026 by

Borderline personality disorder (BPD) is associated with higher risks of a wide range of physical diseases and increased mortality from all causes, natural causes, and external causes, according to a 16-year population-based cohort study in Hong Kong.

16-year HK study: Borderline personality disorder ups risks of physical diseases and mortality

24 Apr 2026

Mediterranean diet may prevent asthma onset in adults

22 Apr 2026 by

Adherence to a Mediterranean diet (MedDiet) appears to reduce the incidence of adult-onset asthma, suggests a recent study, noting that causality cannot be inferred due to its observational design.

Mediterranean diet may prevent asthma onset in adults

22 Apr 2026

Health supplements: Help or hype?

22 Apr 2026 by

A review of 19 meta-analyses shows mixed results on the effects of multivitamin and mineral (MVM) supplementation on health outcomes.

Health supplements: Help or hype?

22 Apr 2026

Rilzabrutinib shows potential in patients with uncontrolled asthma

22 Apr 2026

BTK inhibition with rilzabrutinib does not appear to significantly decrease the incidence of loss-of-asthma-control (LOAC) event compared with placebo in patients with moderate-to-severe asthma with uncontrolled symptoms, according to a phase II study. However, the investigational drug has been associated with meaningful symptom improvements over time, despite withdrawal of background therapy.

Rilzabrutinib shows potential in patients with uncontrolled asthma

22 Apr 2026

T allele presence eases effect of air pollution on RA-ILD risk

21 Apr 2026

People exposed to air pollution for too long are at greater risk of developing rheumatoid arthritis (RA)-associated interstitial lung disease (ILD), with the effect potentially modified according to MUC5B rs35705950 genotype, reveals a study.

T allele presence eases effect of air pollution on RA-ILD risk

21 Apr 2026

COVID-19 ups new-onset respiratory T2ID risk

20 Apr 2026 by

A study shows an association between COVID-19 infection and an elevated risk of new-onset respiratory type 2 inflammatory diseases (T2IDs), while vaccination remains protective against such diseases.

COVID-19 ups new-onset respiratory T2ID risk

20 Apr 2026

Fluvoxamine improves fatigue, QoL in long COVID patients

19 Apr 2026 by

Patients with long COVID may derive benefits from treatment with fluvoxamine, which has been shown to reduce fatigue and improve quality of life (QoL) in a study. The use of metformin, on the other hand, shows no significant advantage.

Fluvoxamine improves fatigue, QoL in long COVID patients

19 Apr 2026

Ultrasound-facilitated, catheter-directed thrombolysis beneficial in intermediate-risk PE

18 Apr 2026 by

In the treatment of patients with acute, intermediate-risk pulmonary embolism (PE), administering ultrasound-facilitated, catheter-directed thrombolysis (USCDT) on top of anticoagulation results in better short-term outcomes compared with anticoagulation alone, as shown in the multinational, adaptive-design, open-label HI-PEITHO trial.

Ultrasound-facilitated, catheter-directed thrombolysis beneficial in intermediate-risk PE

18 Apr 2026

News & Updates

Showing Respirology articles

Showing

Specialty:

ICI efficacy in lung cancer not dictated by time of treatment

ICI efficacy in lung cancer not dictated by time of treatment

Sleep apnoea common among long COVID patients, signalled by insomnia

Sleep apnoea common among long COVID patients, signalled by insomnia

16-year HK study: Borderline personality disorder ups risks of physical diseases and mortality

16-year HK study: Borderline personality disorder ups risks of physical diseases and mortality

Mediterranean diet may prevent asthma onset in adults

Mediterranean diet may prevent asthma onset in adults

Health supplements: Help or hype?

Health supplements: Help or hype?

Rilzabrutinib shows potential in patients with uncontrolled asthma

Rilzabrutinib shows potential in patients with uncontrolled asthma

T allele presence eases effect of air pollution on RA-ILD risk

T allele presence eases effect of air pollution on RA-ILD risk

COVID-19 ups new-onset respiratory T2ID risk

COVID-19 ups new-onset respiratory T2ID risk

Fluvoxamine improves fatigue, QoL in long COVID patients

Fluvoxamine improves fatigue, QoL in long COVID patients

Ultrasound-facilitated, catheter-directed thrombolysis beneficial in intermediate-risk PE

Ultrasound-facilitated, catheter-directed thrombolysis beneficial in intermediate-risk PE